Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ZD-4054 specifically inhibits ETA receptor-mediated antiapoptotic events

Sep. 29, 2004

Inhibition of Hsp90 in the treatment of SCLC

Sep. 29, 2004

PTK-787/ZK-222584 enhances antitumor activity of NVP-LAQ-824

Sep. 29, 2004

Canadian approval for phase I trial of Occlusin

Sep. 29, 2004

ECO-4601 shown to cross blood-brain barrier

Sep. 29, 2004

FDA Advisory Committee to review Marqibo in December

Sep. 29, 2004

Enrollment open in phase I study of AQ4N

Sep. 29, 2004

Novel steryl sulfatase inhibitors discovered at Kyowa Hakko

Sep. 29, 2004

Novel oligoadenylic acid derivatives for use in cancer and viral infections

Sep. 29, 2004

Novel GnRH antagonists in early development at Takeda

Sep. 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...